Clearstead Advisors, LLC Tandem Diabetes Care Inc Transaction History
Clearstead Advisors, LLC
- $7.4 Billion
- Q3 2025
A detailed history of Clearstead Advisors, LLC transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Clearstead Advisors, LLC holds 658 shares of TNDM stock, worth $12,245. This represents 0.0% of its overall portfolio holdings.
Number of Shares
658
Previous 67
882.09%
Holding current value
$12,245
Previous $1,000
600.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding TNDM
# of Institutions
288Shares Held
74.1MCall Options Held
2.94MPut Options Held
362K-
Black Rock Inc. New York, NY11.1MShares$207 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.06MShares$131 Million0.0% of portfolio
-
Sessa Capital Im, L.P. New York, NY5MShares$93.1 Million1.49% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.69MShares$68.7 Million0.96% of portfolio
-
Gw&K Investment Management, LLC Boston, MA2.72MShares$50.6 Million0.29% of portfolio
About TANDEM DIABETES CARE INC
- Ticker TNDM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 64,221,200
- Market Cap $1.2B
- Description
- Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...